Camden National Corporation’s Colgate-Palmolive CL Stock Holding History

Camden National Corporation’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$464K	Buy	+5,890	New	+$462K	0.09%	94

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Camden National Corporation's CL Position: Q1 2021 in Review

Camden National Corporation opened a new position in Colgate-Palmolive (CL) in Q1 2021: 5,890 shares worth $464K. The stake represents 0.09% of the portfolio and ranks #94 among its holdings.

1,607 funds tracked by Wall St. Rank hold CL as of Q1 2021.

Camden National Corporation held 5,890 shares of Colgate-Palmolive worth $464K as of Q1 2021.
Colgate-Palmolive was a new Camden National Corporation position in Q1 2021.
Colgate-Palmolive made up 0.09% of Camden National Corporation's portfolio in Q1 2021, its #94 holding.
1,607 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2021.

Based on Camden National Corporation's 13F filing for Q1 2021, filed 12 May 2021.